KSHV Infection in Blood Donors From Texas

NCT00006310 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-03-10

No results posted yet for this study

Summary

To determine the seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in blood donors from Texas. Also to examine the donors' demographic characteristics and to characterize the KSHV using polymerase chain reaction.

Conditions

  • Blood Donors
  • Acquired Immunodeficiency Syndrome
  • Blood Transfusion
  • Herpesvirus, Kaposi Sarcoma-Associated
  • Sarcoma, Kaposi
  • HIV Infections

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Shou-Jiang Gao, PhD · University of Texas

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-04-30
Completion
2004-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00006310 on ClinicalTrials.gov